Cardinal Health, Inc.
NYSEShort interest in CAH dropped 21% over the past week, even as the healthcare distributor's stock slipped 4.7%. Cardinal Health now has 6.02 million shares sold short as of March 31. That's down from earlier levels but still up 18% over the past month. Days to cover stands at 3.09, indicating shorts could exit positions relatively quickly if needed. Cost to borrow remains minimal at 0.32%, down 5.5% week-over-week. Utilization sits at just 0.68%, well below the 52-week high of 2.57%. These metrics suggest ample share supply for shorting, with little competition for borrows. The stock closed at $204.92 on April 21, down 3% on the day and nearly 5% for the week. Options traders show elevated caution—the put/call ratio of 0.846 runs more than two standard deviations above the 20-day mean of 0.75. Cardinal Health reports earnings April 30. The healthcare distributor operates in a sector facing margin pressure and reimbursement headwinds, though its scale provides some insulation. The short interest decline suggests bears may be taking profits or reducing exposure ahead of the earnings report. With borrowing costs negligible and utilization low, the technical setup shows no signs of squeeze risk. The stock's recent weakness appears driven by broad sector rotation rather than company-specific catalysts. This is not financial advice. Data may contain errors.
Short Sellers Retreat From Cardinal Health
Short interest in CAH dropped 21% over the past week, even as the healthcare distributor's stock slipped 4.7%. Cardinal Health now has 6.02 million shares sold short as of March 31. That's down from earlier levels but still up 18% over the past month. Days to cover stands at 3.09, indicating shorts could exit positions relatively quickly if needed. Cost to borrow remains minimal at 0.32%, down 5.5% week-over-week. Utilization sits at just 0.68%, well below the 52-week high of 2.57%. These metrics suggest ample share supply for shorting, with little competition for borrows. The stock closed at $204.92 on April 21, down 3% on the day and nearly 5% for the week. Options traders show elevated caution—the put/call ratio of 0.846 runs more than two standard deviations above the 20-day mean of 0.75. Cardinal Health reports earnings April 30. The healthcare distributor operates in a sector facing margin pressure and reimbursement headwinds, though its scale provides some insulation. The short interest decline suggests bears may be taking profits or reducing exposure ahead of the earnings report. With borrowing costs negligible and utilization low, the technical setup shows no signs of squeeze risk. The stock's recent weakness appears driven by broad sector rotation rather than company-specific catalysts. This is not financial advice. Data may contain errors.
Snapshot as of 6 May 2026
Cardinal Health heads into the first full week of May under pressure, having shed 4.2% over the past week to close at $197, while the Street digests a mixed earnings signal and a wave of freshly cut price targets. The…
Cardinal Health reports its Q3 2026 results today against an uncomfortable backdrop: the stock is down nearly 7% over the past month, trading at $192.88, and the mean analyst price target of $247 implies roughly 28%…
Cardinal Health reports Q3 fiscal 2026 results this morning — and for once, the pre-print setup tilts notably in the bulls' favour. The most telling move arrived Tuesday, when William Blair initiated coverage with an…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CAH — free to start on ORTEX.
Sign up for free →Open CAH on ORTEX